Stress Level Among Dentists in Performing Treatment

May 23, 2022 updated by: esra kizilci, TC Erciyes University

Stress Level Among Dentists In Performing Treatment In Clinic, Deep Sedation, and General Anesthesia

Purpose: To evaluate the stress levels of dentists working under clinical, deep sedation, or general anaesthesia. Methods: Blood pressure (Systolic, Diastolic blood pressure), Pulse value, O2 saturations were measured, and saliva samples were taken by the dentists 10 minutes before the dental treatment, at the 25th minute of the treatment, and 30 minutes after the treatment under clinic, deep sedation, and general anesthesia. Salivary cortisol was measured by electrochemiluminescence (ECLIA) method using the Cobas Cortisol ll kit. The data are analayse statistically

Study Overview

Detailed Description

Occupational stress, defined as when the resources of the individual are not sufficient to cope with the needs of a situation, is a leading modern health and safety challenge 2.

Although stress is defined as a feeling of tension and pressure, small amounts of stress can be helpful for the individual to cope with difficult situations. The dentist who wants to provide the best treatment for the patient can feel stress and uneasiness when the current conditions are inappropriate. If this stress of dentist is very the desired amount, it can lead to harmful results for patient health.

Especially in pediatric dentistry, behaviour management problems in children, parents' expectations, and behaviours can be more stressful and exhausting in practice. A dentist' s fear and anxiety in children can create various difficulties for the child, parents, dentists, and their team.

Deep sedation is the method in which consciousness is suppressed in a controlled manner by the drug applied, partial loss of protective reflexes, and the response to verbal stimuli is removed. General anaesthesia, on the other hand, is a condition in which the level of patient unconsciousness can be controlled, the patient's protective reflexes are partially or wholly lost, he cannot protect the airway independently, and cannot respond to verbal commands or physical stimuli. Ensuring and maintaining airway patency is vital in sedation applications. In anaesthesia applications, deep sedation in dental procedures is challenging due to the anatomical proximity of the surgical area to the airway, the risk of microaspiration. Dental treatment with general anaesthesia is seen that it is a stressful situation for the practitioner since some complications such as neurological damage, cardiac and respiratory arrest, and even death may occur.

In healthy individuals, stimulation of the sympathetic nervous system at the beginning of the stress response begins with the secretion of epinephrine and norepinephrine from the adrenal medulla. For this reason, sympathetic activity is measured by various evaluation methods such as heart rate, blood pressure, O2 saturation. Salivary cortisol has been accepted as a reliable biomarker of the Hypothalamus-Pituitary-Adrenal system as a delayed stress response.

In the literature review, very few studies investigated occupational stress related to pediatric dentistry. Furthermore, no study was found in which the stress situation in three treatment protocols was evaluated and compared. It was aimed to evaluate the stress which was experienced by dentists working with children while treating children in all three treatment protocols by using objective tests. The H0 hypothesis of the study is that the stress levels of dentists change according to the different treatment protocols.

METHODS This study was approval required for the study was obtained by the clinical research ethics committee from University (No: 82021/32) and conducted following the principles of the Declaration of Helsinki. Both the parents and their children and dentists who agreed to participate in the study provided informed consent.

According to the power analysis, the estimated number of samples was determined as 9 patients in each groups (α error 0.05 and 1-β=0.80). Therefore, each dentist treated 27 patients in 3 different treatment approaches, and the study resulted in a total of 108 patients.Blood pressure (Systolic, Diastolic blood pressure), Pulse value, O2 saturations were measured, and saliva samples were taken by the dentists 10 minutes before the dental treatment, at the 25th minute of the treatment, and 30 minutes after the treatment for all 3 treatment approaches The Saliva Swab Sample Collection kit was used to collect saliva samples. It was placed under the tongue for 2 minutes and was ensured that the swab absorbed the saliva. Afterwards, the swab was centrifuged and placed in saliva storage tubes with a perforated chamber for separating saliva and remaining dry swab. Samples were centrifuged at 3000 rpm for 15 minutes, saliva was cleared of debris and poured to the bottom of the storage tube. Then, saliva in the plastic saliva storage tube was stored at -80 ºC in an upright position until measurements were made 30. After the saliva samples were thawed at room temperature on the day of the measurements, they were taken to the University Medical Faculty Central Biochemistry Laboratory for analysis.

Salivary Cortisol Measurement Protocol:

Salivary cortisol was measured by electrochemiluminescence (ECLIA) method using the Cobas Cortisol ll kit (Roche Diagnostics GmbH; Mannheim, Germany).

10 µL of sample is incubated with cortisol-specific biotinylated antibody and cortisol derivative labelled with ruthenium complex. Depending on the analyte concentration in the sample and the formation of the respective immune complex, the labelled antibody binding site is filled partly with the sample analyte and partly with the ruthenium hapten.

After streptavidin-coated microparticles have been added, biotin and streptavidin interact. The complex becomes bound to the solid phase.

The reaction mixture is aspirated into the measuring cell on the surface of the electrode. The measuring cell is that the microparticles, magnetically, are captured. Unbound substances are then removed with ProCell/ProCell M. Applying voltage to the electrode induces chemiluminescence emission, which is measured with a photomultiplier.

An instrument-specific calibration curve determines results with 2-point calibration and a master curve acquired via the reagent barcode 30.

Statistical analysis In the study, the analyzes were made with the SPSS 25.0 program. On the analysis of data, descriptive statistics are presented with mean and standard deviation values. In the study, the Kruskal Wallis test was performed to examine the differences in measurements according to dentists and treatment approaches. Mann Whitney U test was used to reveal the evaluation that caused the difference. The Friedman test was used to examine the differences between the measurements in the treatment approaches before, during, and after the procedure.

Results When the findings are evaluated according to the measurement times: systolic and diastolic blood pressure measurements for all dentists before the procedure are similar in clinical, general anaesthesia, and sedation (p>0.05). During the procedure, both systolic and diastolic blood pressure measurements were found to be higher under the deep sedation (p<0.05). It was determined that systolic blood pressure measurements did not differ according to under clinical, general anaesthesia, and deep sedation after the procedure (p>0.05), but diastolic blood pressure measurements differed according to treatment approaches. The measurements under the deep sedation were higher than the clinical and general anaesthesia (p<0.05). Pulse and oxygen saturation measurements before, during, and after the treatment did not differ under clinical, general anaesthesia, and deep sedation. It was observed that cortisol measurements before and during the treatment were not at different levels compared to clinical, general anaesthesia, and deep sedation (p>0.05). After the procedure, cortisol measurements under the deep sedation were higher than clinical and general anaesthesia (p<0.05).

It was observed that the heart rate measurements were at similar levels before, during, and after the procedure under clinical and general anaesthesia. Under the deep sedation, it was determined that the heart rate measurements during the procedure were at higher levels than before and after the procedure (p<0.05).

When authors evaluated the oxygen saturation measurements, the oxygen saturation during the procedure was lower than before and after the procedure.

Cortisol measurements were found to be at different levels according to the processing times in Table 2.

Study Type

Interventional

Enrollment (Actual)

4

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kayseri, Turkey, 38000
        • Esra Kizilci

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 33 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • 4 dentists, who started their specialization training, simultaneously in Erciyes University Faculty of Dentistry, Department of Pediatric Dentistry, with equal clinical experience and training.
  • Woman
  • Between the ages of 30-33
  • Weights 52-55 kg
  • No systemic disease
  • Dentists who have actively treated patients for at least 2 years in a clinic, with deep sedation and general anaesthesia are included.

Exclusion Criteria:

  • Children who were previously hospitalized due to health problems or who did not live with their biological family were also excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: clinical treatment

4 dentist treated 36 patient in clinical group

- For treatment in a clinic, children with positive or definitely positive (Frankl 3 and 4) behaviour according to the Frankl Scale (Behavior Evaluation Scale) 28, with the data observed in the first session, were included in the clinical treatment group. According to the clinical examination of these patients, 36 healthy children aged 5-6 years who did not require pulpal treatment and whose caries level was 1-4 according to the ICDAS (International Caries Detection And Assessment System) 29 scoring were selected. The limits of the treatment were determined as compomer filling applied to 2 primary molars after local anaesthesia, and the duration of the treatment was limited to 30 to 60 minutes.

Salivary cortisol was measured by electrochemiluminescence (ECLIA) method using the Cobas Cortisol ll kit.
Other Names:
  • Salivary cortisol
Experimental: deep sedation

4 dentist treated 36 patient in clinical group

- Children aged 48-72 months, children with negative or absolutely negative behaviour (Frankl 1 and 2) according to the Frankl Scale, were reserved for treatment under deep sedation. In order to provide standardization among patients suitable for sedation, 36 children (n=9) whose dmft (decayed, missing, filled teeth index) were less than their age, and the duration of the procedure would be limited to between 30 and 40 minutes, were included in the study.

Salivary cortisol was measured by electrochemiluminescence (ECLIA) method using the Cobas Cortisol ll kit.
Other Names:
  • Salivary cortisol
Experimental: general anaesthesia

4 dentist treated 36 patient in clinical group

- Children aged 48-72 months, children with negative or definitely negative behaviour according to the Frankl Scale (Frankl 1 and 2), were reserved for treatment under general anaesthesia. In order to provide standardization among patients suitable for general anaesthesia, 36 healthy children (n=9) whose dmft was equal to, or higher than their age were allocated. In addition, patients whose treatment time would be limited to 30 to 60 minutes were included.

Salivary cortisol was measured by electrochemiluminescence (ECLIA) method using the Cobas Cortisol ll kit.
Other Names:
  • Salivary cortisol

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Salivary cortisol
Time Frame: saliva samples were taken by the dentists 10 minutes before the dental treatment
Salivary cortisol was measured by electrochemiluminescence (ECLIA) method using the Cobas Cortisol ll kit.
saliva samples were taken by the dentists 10 minutes before the dental treatment
Salivary cortisol
Time Frame: saliva samples were taken by the dentists at the 25th minute of the treatment
Salivary cortisol was measured by electrochemiluminescence (ECLIA) method using the Cobas Cortisol ll kit.
saliva samples were taken by the dentists at the 25th minute of the treatment
Salivary cortisol
Time Frame: saliva samples were taken by the dentists at the 30 minutes after the treatment
Salivary cortisol was measured by electrochemiluminescence (ECLIA) method using the Cobas Cortisol ll kit.
saliva samples were taken by the dentists at the 30 minutes after the treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Systolic, Blood pressure
Time Frame: Systolic Blood pressure were measured by the dentists 10 minutes before the dental treatment
Systolic Blood pressure were measured with Automatic Wrist Blood Pressure Monitor, as (mmHg)
Systolic Blood pressure were measured by the dentists 10 minutes before the dental treatment
Diastolic Blood pressure
Time Frame: Diastolic Blood pressure were measured by the dentists 10 minutes before the dental treatment
Diastolic Blood pressure were measured with Automatic Wrist Blood Pressure Monitor, as (mmHg)
Diastolic Blood pressure were measured by the dentists 10 minutes before the dental treatment
Systolic Blood pressure
Time Frame: Systolic Blood pressure were measured by the dentists at the 25th minute of the treatment
Systolic Blood pressure were measured with Automatic Wrist Blood Pressure Monitor, as (mmHg)
Systolic Blood pressure were measured by the dentists at the 25th minute of the treatment
Diastolic Blood pressure
Time Frame: Diastolic Blood pressure were measured by the dentists at the 25th minute of the treatment
Diastolic Blood pressure were measured with Automatic Wrist Blood Pressure Monitor, as (mmHg)
Diastolic Blood pressure were measured by the dentists at the 25th minute of the treatment
Systolic Blood pressure
Time Frame: Systolic Blood pressure were measured by the dentists 30 minutes after the treatment
Systolic Blood pressure were measured with Automatic Wrist Blood Pressure Monitor, as (mmHg)
Systolic Blood pressure were measured by the dentists 30 minutes after the treatment
Diastolic Blood pressure
Time Frame: Diastolic Blood pressure were measured by the dentists 30 minutes after the treatment
Diastolic Blood pressure were measured with Automatic Wrist Blood Pressure Monitor, as (mmHg)
Diastolic Blood pressure were measured by the dentists 30 minutes after the treatment

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pulse value
Time Frame: Pulse value were measured by the dentists 10 minutes before the dental treatment
Pulse value were measured, with Braun YK-81CEU Pulse oximeter, as PRbpm
Pulse value were measured by the dentists 10 minutes before the dental treatment
Pulse value
Time Frame: Pulse value were measured by the dentists at the 25th minute of the treatment
Pulse value were measured, with Braun YK-81CEU Pulse oximeter, as PRbpm
Pulse value were measured by the dentists at the 25th minute of the treatment
Pulse value
Time Frame: Pulse value were measured by the dentists 30 minutes after the treatment
Pulse value were measured, with Braun YK-81CEU Pulse oximeter, as PRbpm
Pulse value were measured by the dentists 30 minutes after the treatment
O2 saturations
Time Frame: O2 saturations were measured by the dentists at the 25th minute of the treatment
O2 saturations were measured with with Braun YK-81CEU Pulse oximeter, SpO2, %
O2 saturations were measured by the dentists at the 25th minute of the treatment
O2 saturations
Time Frame: O2 saturations were measured by the dentists 30 minutes after the treatment
O2 saturations were measured with Braun YK-81CEU Pulse oximeter, SpO2, %
O2 saturations were measured by the dentists 30 minutes after the treatment
O2 saturations
Time Frame: Pulse value were measured by the dentists 10 minutes before the dental treatment
O2 saturations were measured with Braun YK-81CEU Pulse oximeter, SpO2, %
Pulse value were measured by the dentists 10 minutes before the dental treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: ESRA KIZILCI, 1, erciyes university pediatric dentistry

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 20, 2021

Primary Completion (Actual)

April 24, 2021

Study Completion (Actual)

August 14, 2021

Study Registration Dates

First Submitted

January 2, 2022

First Submitted That Met QC Criteria

May 23, 2022

First Posted (Actual)

May 27, 2022

Study Record Updates

Last Update Posted (Actual)

May 27, 2022

Last Update Submitted That Met QC Criteria

May 23, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The raw data are available in the authors

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress, Job

Subscribe